Dengue: a continuing global threat
Open accessThe DOI matches its Crossref record; 129 of the 130 references it cites were found in a registry or an index.
Abstract
Dengue fever and dengue haemorrhagic fever are important arthropod-borne viral diseases. Each year, there are ∼50 million dengue infections and ∼500,000 individuals are hospitalized with dengue haemorrhagic fever, mainly in Southeast Asia, the Pacific and the Americas. Illness is produced by any of the four dengue virus serotypes. A global strategy aimed at increasing the capacity for surveillance and outbreak response, changing behaviours and reducing the disease burden using integrated vector management in conjunction with early and accurate diagnosis has been advocated. Antiviral drugs and vaccines that are currently under development could also make an important contribution to dengue control in the future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Until recent advances in vaccine development [16–17], and the approval and potential availability of the first product in 2016 [18], dengue has been unique among the major vector-borne diseases, in that prevention from infection could only be attempted by reducing or eliminating bites by infected vector mosquitoes [19, 20].”
From Is Dengue Vector Control Deficient in Effectiveness or Evidence?: Systematic Review and Meta-analysis (2016) · cites this paper as [20]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Although a vaccine could be available as early as 2016, vector control remains the primary approach used to prevent dengue, the most common and widespread arbovirus of humans worldwide.”
From Is Dengue Vector Control Deficient in Effectiveness or Evidence?: Systematic Review and Meta-analysis (2016) · cites this paper as [20]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dengue and Dengue Hemorrhagic Fever
Gubler, D. J. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.3.480 · Cited by 4,310
Self-citationLanciotti, R. S., Calisher, C. H., Gubler, D. J., Chang, G. J., & Vorndam, A. V. (1992) · Journal of Clinical Microbiology · doi:10.1128/jcm.30.3.545-551.1992 · Cited by 1,818 · cited 1×
“The most E u r op e P M C F und e r s A u t ho r M a nu s c r i p t s E u r op e P M C F und e r s A u t ho r M a nu s c r i p t s commonly used NAATs are based on a single RT-PCR assay 95,96 , a nested RT-PCR assay 96 or a one-step multiplex RT-PCR assay 97 .”
MethodSelf-citationDengue Viremia Titer, Antibody Response Pattern, and Virus Serotype Correlate with Disease Severity
Vaughn, D. W., Green, S., Kalayanarooj, S., Innis, B. L., Nimmannitya, S., Suntayakorn, S., Endy, T. P., Raengsakulrach, B., Rothman, A. L., Ennis, F. A., et al. (2000) · The Journal of Infectious Diseases · doi:10.1086/315215 · Cited by 1,632 · cited 1×
“One advantage of this assay is the ability to determine viral titre early in dengue illness, which is believed to be an important predictor of disease severity 102 .”
BackgroundGuzmán, M. G., & Kouri, G. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(01)00171-2 · Cited by 1,163
Spectrum of Disease and Relation to Place of Exposure among Ill Returned Travelers
Freedman, D. O., Weld, L. H., Kozarsky, P. E., Fisk, T., Robins, R., von Sonnenburg, F., Keystone, J. S., Pandey, P., & Cetron, M. S. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa051331 · Cited by 1,081
Dengue and dengue haemorrhagic fever
Rigau-Pérez, J. G., Clark, G. G., Gubler, D. J., Reiter, P., Sanders, E. J., & Vance Vorndam, A. (1998) · The Lancet · doi:10.1016/s0140-6736(97)12483-7 · Cited by 1,051
Self-citationCross-Reacting Antibodies Enhance Dengue Virus Infection in Humans
Dejnirattisai, W., Jumnainsong, A., Onsirisakul, N., Fitton, P., Vasanawathana, S., Limpitikul, W., Puttikhunt, C., Edwards, C., Duangchinda, T., Supasa, S., et al. (2010) · Science · doi:10.1126/science.1185181 · Cited by 943 · cited 1×
“The available data suggest that neutralizing antibodies are the major contributors to protective immunity 124,125 , however the role of the cellular immune response requires further study 123 .”
BackgroundCalisher, C. H., Karabatsos, N., Dalrymple, J. M., Shope, R. E., Porterfield, J. S., Westaway, E. G., & Brandt, W. E. (1989) · Journal of General Virology · doi:10.1099/0022-1317-70-1-37 · Cited by 893 · cited 1×
“These tests are mainly for research and vaccine studies 90–94 .”
BackgroundOriginal antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever
Mongkolsapaya, J., Dejnirattisai, W., Xu, X.-N., Vasanawathana, S., Tangthawornchaikul, N., Chairunsri, A., Sawasdivorn, S., Duangchinda, T., Dong, T., Rowland-Jones, S., et al. (2003) · Nature Medicine · doi:10.1038/nm887 · Cited by 821 · cited 1×
“…CD4 + and CD8 + cells that have a diminished capacity to kill but nonetheless release inflammatory cytokines that contribute to disease severity 51 ; that severe disease is caused by DENVs of increased virulence 52 ; and the suggestion that cross-reactivity between NS1 and human platelets and…”
BackgroundDengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody
Halstead, S., & O'Rourke, E. (1977) · The Journal of Experimental Medicine · doi:10.1084/jem.146.1.201 · Cited by 804 · cited 5×
“Both in vitro and in vivo , macrophages and monocytes participate in antibody-dependent enhancement (ADE) 18–20 .”
BackgroundInfluentialSelf-citation
Research works printed but not linked: 3
- Vorndam, V. & Kuno, G. In Dengue and Dengue Hemorrhagic Fever (eds Gubler, D. J. & Kuno, G.) 313–333 (CAB International, New York, USA, 1997).
- Gubler, D. J. Serologic diagnosis of dengue/dengue haemorrhagic fever. Dengue Bull. 20, 20–23 (1996).
- Singh, K. R. P. & Paul, S. D. Multiplication of arboviruses in cell lines from Aedes albopictus and Aedes aegypti. Curr. Sci. 37, 65–67 (1968).
Cited by
Items 301–400 of 1,001
Optical diagnosis of dengue virus infection in human blood serum using Raman spectroscopy
Saleem, M. S., Bilal, M., Anwar, S., Rehman, A. U., & Ahmed, M. (2013) · Laser Physics Letters · doi:10.1088/1612-2011/10/3/035602 · Cited by 60
The genetics of chemoreception in the labella and tarsi of Aedes aegypti
Sparks, J. T., Bohbot, J. D., & Dickens, J. C. (2014) · Insect Biochemistry and Molecular Biology · doi:10.1016/j.ibmb.2014.02.004 · Cited by 67
“The global health risks associatedwith this disease vector are increasing (Bhatt et al., 2013; Guzman et al., 2010; Barrett and Higgs, 2007), as these mosquitoes thrive in urban environments.”
BackgroundLung in Dengue: Computed Tomography Findings
Rodrigues, R. S., Brum, A. L. G., Paes, M. V., Póvoa, T. F., Basílio‐de‐Oliveira, C. A., Marchiori, E. D. S., Borghi, D. P., Ramos, G. V., & Bozza, F. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096313 · Cited by 60
“Rapid expansion of the numbers of cases and countries affected by the disease has been observed in recent years, rendering dengue the most significant re-emerging infectious disease, especially in tropical and subtropical regions [1].”
BackgroundGenomic approaches for understanding dengue: insights from the virus, vector, and host
Sim, S., & Hibberd, M. L. (2016) · Genome biology · doi:10.1186/s13059-016-0907-2 · Cited by 74
“Within each of the four DENV serotypes, which share ~65–70 % amino acid sequence similarity [20], virus strains are further classified into distinct genotypes, which can vary by ~6–8 % at the nucleotide level and by 3 % at the amino acid level [21–24].”
BackgroundMirza, S. B., Salmas, R. E., Fatmi, M. Q., & Durdağı, S. (2016) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2016.03.008 · Cited by 60
Alarm Variables for Dengue Outbreaks: A Multi-Centre Study in Asia and Latin America
Bowman, L., Tejeda, G. S., Coelho, G. E., Sulaiman, L. H., Gill, B. S., McCall, P. J., Olliaro, P., Ranzinger, S. R., Quang, L. C., Skewes-Ramm, R., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0157971 · Cited by 64
“Indeed these differences could also be due to the presence of co-circulating infections with similar clinical presentations, such as Chikungunya or Zika viruses [50,51], which may be confounding probable dengue case diagnoses, or because case definitions are less specific (or likely a combination of both) [4,52].”
BackgroundSelf-citationClinical Focus: Infections in Pregnancy
Adler, H., & Lambert, J. S. (2014) · Hospital Practice · doi:10.3810/hp.2014.04.1109 · Cited by 59
Seeking heterocyclic scaffolds as antivirals against dengue virus
De, S., Aamna, B., Sahu, R., Parida, S., Behera, S. K., & Dan, A. K. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114576 · Cited by 59
“(2019) reported a new [1,2,4]Triazolo [1,5-a]pyrimidine analog (Fig.”
BackgroundVirus interactions with endothelial cell receptors: implications for viral pathogenesis
Dalrymple, N. A., & Mackow, E. R. (2014) · Current Opinion in Virology · doi:10.1016/j.coviro.2014.06.006 · Cited by 64
“Endothelial cells and dengue virus Dengue virus is a mosquito-borne flavivirus that causes a mild febrile illness, dengue fever (DF), and two highly lethal vascular permeability based diseases: dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS) [44,45].”
InfluentialEarly circulating biomarker detection using a wearable microprojection array skin patch
Coffey, J. W., Corrie, S. R., & Kendall, M. A. F. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.08.078 · Cited by 62
“Increasing biomarker capture may lead to more sensitive early detection of biomarkers, which can lead to improved patient outcomes and infectious disease management for many disease scenarios [34,35].”
BackgroundRNAi: antiviral therapy against dengue virus
Idrees, S., & Ashfaq, U. A. (2013) · Asian Pacific Journal of Tropical Biomedicine · doi:10.1016/s2221-1691(13)60057-x · Cited by 59
“5 billion people in tropical and sub-tropical regions of the world[1,2].”
BackgroundWahala, W. M. P. B., Huang, C. Y. ‐., Butrapet, S., White, L., & de Silva, A. M. (2012) · Journal of Virology · doi:10.1128/jvi.06871-11 · Cited by 59
“Dengue viruses (DENV) are emerging, mosquito-borne flaviviruses of humans (10).”
BackgroundChuang, Y., Lin, J., Lin, Y.-S., Wang, S., & Yeh, T. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500057 · Cited by 59
“40% of the world’s population, live in dengue-endemic countries (1, 2).”
BackgroundPiccini, L. E., Castilla, V., & Damonte, E. B. (2015) · PLoS ONE · doi:10.1371/journal.pone.0140824 · Cited by 59
Thalagala, N., Tissera, H. A., Palihawadana, P., Amarasinghe, A., Ambagahawita, A., Wilder‐Smith, A., Shepard, D. S., & Tozan, Y. (2016) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0004466 · Cited by 59
“Commensurate with increases in the size, duration and frequency of dengue epidemics, the incidence of DF and DHF and the rate of dengue hospitalizations have increased markedly in the past few decades [3 – 5], most noticeably in Southeast Asia [6].”
Dengue in Java, Indonesia: Relevance of Mosquito Indices as Risk Predictors
Wijayanti, S. P. M., Sunaryo, S., Suprihatin, S., McFarlane, M., Rainey, S. M., Dietrich, I., Schnettler, E., Biek, R., & Kohl, A. (2016) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0004500 · Cited by 59
“albopictus can also act as a vector [2–5].”
BackgroundToro, M. D., Echavarría-Consuegra, L., Flipse, J., Fernández, G. J., Kluiver, J. L., van den Berg, A., Inchima, S. U., & Smit, J. M. (2017) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0005981 · Cited by 61
“There are four antigenically distinct serotypes of DENV (DENV-1 to -4) which cocirculate in endemic areas [1].”
BackgroundTamura, T., Zhang, J., Madan, V., Biswas, A. G., Schwoerer, M. P., Cafiero, T. R., Heller, B. L., Wang, W., & Ploß, A. (2021) · Emerging Microbes & Infections · doi:10.1080/22221751.2021.2021808 · Cited by 67
“In humans, DENV causes acute infection and viremia is resolved thereafter within a week [47].”
BackgroundEarly Clinical Features of Dengue Virus Infection in Nicaraguan Children: A Longitudinal Analysis
Biswas, H. H., Ortega, O. R. D. R., Gordon, A. L., Standish, K. R., Balmaseda, Á., Kuan, G. M., & Harris, E. (2012) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0001562 · Cited by 58
“However, in some cases, mainly children, illness progresses to life-threatening dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS), characterized by vascular leakage leading to hypovolemic shock and a case fatality rate up to 5% [1,3,4].”
BackgroundLobigs, M., & Diamond, M. (2012) · Expert Review of Vaccines · doi:10.1586/erv.11.180 · Cited by 58
Stein, D. A., Perry, S. T., Buck, M. D., OEHMEN, C. S., Fischer, M. A., Poore, E. A., Smith, J. L., Lancaster, A. M., Hirsch, A. J., Slifka, M. K., et al. (2011) · Journal of Virology · doi:10.1128/jvi.05298-11 · Cited by 63
“Infection by various strains from each serotype can cause severe disease in humans, and all four serotypes now circulate globally (24, 27).”
BackgroundUtility of Humanized BLT Mice for Analysis of Dengue Virus Infection and Antiviral Drug Testing
Frias‐Staheli, N., Dorner, M., Marukian, S., Billerbeck, E., Labitt, R. N., Rice, C. M., & Ploß, A. (2013) · Journal of Virology · doi:10.1128/jvi.03085-13 · Cited by 58
Phanthanawiboon, S., Limkittikul, K., Sakai, Y., Takakura, N., Saijo, M., & Kurosu, T. (2016) · PLoS ONE · doi:10.1371/journal.pone.0148564 · Cited by 66
“The World Health Organization estimates that there may be 390 million DENV infections worldwide every year, resulting in approximately 25,000 deaths [1].”
BackgroundBergamaschi, G., Fassi, E. M. A., Romanato, A., D’Annessa, I., Odinolfi, M. T., Brambilla, D., Damin, F., Chiari, M., Gori, A., Colombo, G., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20081921 · Cited by 57
“We focused on the dengue envelope (E) protein, since the important biological properties of dengue viruses, including the induction of neutralizing antibodies and protective immune responses, are associated with this glycoprotein [1].”
BackgroundReliable Serological Diagnostic Tests for Arboviruses: Feasible or Utopia?
Kerkhof, K., Falconi‐Agapito, F., Esbroeck, M. V., Talledo, M., & Ariën, K. K. (2019) · Trends in Microbiology · doi:10.1016/j.tim.2019.11.005 · Cited by 65
Awan, M., Rauf, S., Abbas, A., Nawaz, M. H., Yang, C. P., Shahid, S. A., Amin, N., & Hayat, A. (2020) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2020.114014 · Cited by 57
Pillay, K., Keddie, S., Fitchett, E. J. A., Akinde, C., Baerenbold, O., Bradley, J., Falconer, J., Keogh, R. H., Lim, Z. N., Maldonado, B. N., et al. (2025) · The Lancet Microbe · doi:10.1016/j.lanmic.2025.101088 · Cited by 68
Force of infection of dengue serotypes in a population-based study in the northeast of Brazil
Castanha, P. M. S., Cordeiro, M. T., Martelli, C. M. T., de Souza, W. V., Marques, E. T. A., & Braga, C. (2012) · Epidemiology and Infection · doi:10.1017/s0950268812001367 · Cited by 57
“Dengue is a leading cause of morbidity and mortality in tropical and subtropical regions and demands progressive efforts and investments by the countries in which it is endemic [1].”
BackgroundThe Association of Cytokines with Severe Dengue in Children
Mangione, J. N. A., Huy, N. T., Lan, N. T. P., Mbanefo, E. C., Ha, T. T. N., Lam, B., Nga, C. T. P., Tuong, V. V., Dat, T. V., Thúy, T. T., et al. (2014) · Tropical Medicine and Health · doi:10.2149/tmh.2014-09 · Cited by 60
“The combined data were used to classify the dengue patients in the categories DF, DHF and DSS according to the 1997 WHO guidelines [5].”
MethodPal, S., Dauner, A. L., Valks, A., Forshey, B. M., Long, K. C., Thaisomboonsuk, B., Sierra, G., Picos, V., Talmage, S., Morrison, A. C., et al. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.03042-14 · Cited by 57
“The severity of the disease can range from asymptomatic or mild to severe with high fever, hemorrhage, and shock (2, 5).”
BackgroundQuantifying the added value of climate information in a spatio-temporal dengue model
Lowe, R., Cazelles, B., Paul, R. E. L., & Rodó, X. (2015) · Stochastic Environmental Research and Risk Assessment · doi:10.1007/s00477-015-1053-1 · Cited by 63
“Dengue is an emerging vector-borne viral disease, ubiquitous in the tropics and the subtropics, particularly in Southeast Asia, the Pacific and the Americas (Guzman et al., 2010).”
BackgroundVersiani, A. F., Astigarraga, R. G., Rocha, E. S. D. O., Barboza, A. P. M., Kroon, E. G., Rachid, M. A., Souza, D. G., Ladeira, L. O., Barbosa‐Stancioli, E. F., Jório, A., et al. (2017) · Journal of Nanobiotechnology · doi:10.1186/s12951-017-0259-4 · Cited by 57
“Background Dengue is currently the most prevalent arthropod-borne viral disease in the world [1].”
BackgroundProlonged persistence of IgM against dengue virus detected by commonly used commercial assays
Chien, Y., Liu, Z.-H., Tseng, F., Ho, T., Guo, H., Ko, N., Ko, W., & Perng, G. (2018) · BMC Infectious Diseases · doi:10.1186/s12879-018-3058-0 · Cited by 57
Casos de dengue e coleta de lixo urbano: um estudo na Cidade do Recife, Brasil
Sobral, M. F. F., & Sobral, A. I. G. D. P. (2019) · Ciência & Saúde Coletiva · doi:10.1590/1413-81232018243.10702017 · Cited by 61
Risk factors associated with severe dengue in Latin America: A systematic review and meta‐analysis
Paraná, V. C., Feitosa, C. A., da Silva, G. C. S., Gois, L. L., & Santos, L. A. (2024) · Tropical Medicine & International Health · doi:10.1111/tmi.13968 · Cited by 61
de la Cruz, L., Chen, W., Graham, B., & Otting, G. (2014) · FEBS Journal · doi:10.1111/febs.12729 · Cited by 56
Marimuthu, S., Rahuman, A. A., Kirthi, A. V., Santhoshkumar, T., Jayaseelan, C., & Rajakumar, G. (2013) · Parasitology Research · doi:10.1007/s00436-013-3601-2 · Cited by 56
Prediction of High Incidence of Dengue in the Philippines
Buczak, A. L., Baugher, B. D., Babin, S. M., Ramac-Thomas, L. C., Guven, E., Elbert, Y., Koshute, P. T., Velasco, J. M., Roque, V. G., Tayag, E. A., et al. (2014) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0002771 · Cited by 57
“There are four known serotypes of the virus, although the initial clinical presentations are almost identical [3].”
BackgroundChen, H., Liu, S., Li, Y.-S., Liu, H., Tsai, J.-P., Chiang, C.-Y., Chen, M., Hwang, C.-S., Huang, C., Hu, H., et al. (2013) · Archives of Virology · doi:10.1007/s00705-013-1639-1 · Cited by 56
“5 billion people in tropical and subtropical regions of the world are at risk of infection, and the incidence of dengue has increased significantly in recent decades [16].”
BackgroundDiagnosing dengue virus infection: rapid tests and the role of micro/nanotechnologies
Zhang, B., Salieb–Beugelaar, G. B., Nigo, M. M., Weidmann, M., & Hunziker, P. (2015) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2015.05.009 · Cited by 68
Kao, Y.-H., & Eisenberg, M. C. (2018) · Epidemics · doi:10.1016/j.epidem.2018.05.010 · Cited by 77
“These increases are primarily attributed to the habitat expansion of Aedes spp. caused by changes in anthropogenic land use and human movement (Wilder-Smith and Gubler, 2008; Guzman et al., 2010; Gubler, 2011; Weaver, 2013; Wilder-Smith, 2012; Powell and Tabachnick, 2013).”
Epidemiology and costs of dengue in Thailand: A systematic literature review
Thisyakorn, U., Saokaew, S., Gallagher, E., Kastner, R., Sruamsiri, R., Oliver, L., & Hanley, R. (2022) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0010966 · Cited by 55
Understanding Dengue Virus Capsid Protein Disordered N-Terminus and pep14-23-Based Inhibition
Faustino, A. F., Guerra, G. M., Huber, R. G., Hollmann, A., Domingues, M. M., Barbosa, G. M., Enguita, F. J., Bond, P. J., Castanho, M. A. R. B., Poian, A. T. D., et al. (2014) · ACS Chemical Biology · doi:10.1021/cb500640t · Cited by 58
Dengue Virus Type 3 Adaptive Changes during Epidemics in São Jose de Rio Preto, Brazil, 2006–2007
Villabona‐Arenas, C. J., Mondini, A., Bosch, I., Schimitt, D., Calzavara-Silva, C. E., Zanotto, P. M. D. A., & Nogueira, M. L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063496 · Cited by 58
“Dengue viruses (genus flavivirus, family Flaviviridae) are responsible for dengue fever and severe dengue (previously known as dengue hemorrhagic fever, DHF and dengue shock syndrome, DSS), they are some of the most important arthropod-borne viral diseases worldwide [1–4].”
BackgroundDetection of Dengue Virus NS1 Antigen in Infected Aedes aegypti Using a Commercially Available Kit
Voge, N. V., Sánchez-Vargas, I., Blair, C. D., Eisen, L., & Beaty, B. J. (2012) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2012.12-0477 · Cited by 55
Current status of the development of dengue vaccines
Lee, M. F., Long, C. M., & Poh, C. L. (2024) · Vaccine X · doi:10.1016/j.jvacx.2024.100604 · Cited by 74
Harenberg, A., Begue, S., Mamessier, A., Gimenez-Fourage, S., Seah, C. C., Liang, A. W., Ng, J. L., Toh, X. Y., Archuleta, S., Wilder‐Smith, A., et al. (2013) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.25562 · Cited by 54
“Over the past two decades, the number of dengue infections has continued to increase in the endemic areas of South-east Asia, Central and South America and the South Pacific regions.(1,2) Immune responses to natural infection are thought to provide lifelong protection against homoserotypic strains, but limited cross-p…”
BackgroundUniversal Single-Probe RT-PCR Assay for Diagnosis of Dengue Virus Infections
Alm, E., Lesko, B., Lindegren, G., Ahlm, C., Söderholm, S., Falk, K. I., & Lagerqvist, N. (2014) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0003416 · Cited by 55
“IgM antibodies appear by day 2 to 5 of illness [24,25], whereas IgG antibodies generally become detectable at the end of the first week after onset of symptoms [2].”
BackgroundDevelopment of a recombinant, chimeric tetravalent dengue vaccine candidate
Osorio, J. E., Partidos, C. D., Wallace, D., & Stinchcomb, D. T. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.11.022 · Cited by 54
“5 kilobase RNA genome ncoding three structural proteins – the capsid (C), pre-membrane prM) and envelope (E) glyco-proteins – and seven non-structural NS) proteins [1].”
BackgroundInfluentialThe molecular and clinical features of dengue during outbreak in Jambi, Indonesia in 2015
Haryanto, S., Hayati, R., Yohan, B., Sijabat, L., Sihite, I. F., Fahri, S., Meutiawati, F., Halim, J. A. N., Halim, S. N., Soebandrio, A., et al. (2016) · Pathogens and Global Health · doi:10.1080/20477724.2016.1184864 · Cited by 54
Santos, M. C. D., Nascimento, Y. M., de Araújo, J. M. G., & Lima, K. M. G. (2017) · RSC Advances · doi:10.1039/c7ra03361c · Cited by 54
Evidence for the natural occurrence of Wolbachia in Aedes aegypti mosquitoes
Balaji, S., Jayachandran, S., & Prabagaran, S. R. (2019) · FEMS Microbiology Letters · doi:10.1093/femsle/fnz055 · Cited by 54
Designing effective control of dengue with combined interventions
Hladish, T. J., Pearson, C. A. B., Toh, K. B., Rojas, D. P., Manrique-Saide, P. C., Vazquez‐Prokopec, G. M., Halloran, M. E., & Longini, I. M. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1903496117 · Cited by 61
Efficacy and community effectiveness of larvivorous fish for dengue vector control
Han, W. W., Lazaro, A., McCall, P. J., George, L., Runge‐Ranzinger, S., Toledo, J., Velayudhan, R., & Horstick, O. (2015) · Tropical Medicine & International Health · doi:10.1111/tmi.12538 · Cited by 53
Koishi, A. C., Zanello, P. R., Bianco, Έ. M., Bordignon, J., & dos Santos, C. N. D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051089 · Cited by 55
“The severity of disease might be related to strain virulence, host factors and/or secondary infections with heterologous serotypes [6–8] suggesting that immunopathological mechanisms are involved with the disease progression [9,10].”
BackgroundChuang, Y., Lin, Y.-S., Liu, H., & Yeh, T. (2014) · Journal of Virology · doi:10.1128/jvi.02166-14 · Cited by 53
“DENV RNA encodes a polyprotein, including a capsid (C), premembrane (prM), and envelope (E) protein and 7 nonstructural (NS) proteins (1).”
BackgroundPeptide Inhibitors Against Dengue Virus Infection
Panya, A., Bangphoomi, K., Choowongkomon, K., & Yenchitsomanus, P. (2014) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12309 · Cited by 53
“It is estimated that approximately 50 million people are infected and over 20 000 people died each year (1).”
BackgroundCurrent perspectives on dengue episode in Malaysia
Pang, E. L., & Loh, H. (2016) · Asian Pacific Journal of Tropical Medicine · doi:10.1016/j.apjtm.2016.03.004 · Cited by 53
“As infecting virus is being circulated in the peripheral blood of patients, a mosquito's bite during febrile viraemic stage would result in disease being transmitted to another host after an extrinsic incubation period [13].”
BackgroundDengue fever – an update review and implications for Nigeria, and similar countries
Otu, A. A., Ebenso, B., Etokidem, A. J., & Chukwuekezie, O. C. (2019) · African Health Sciences · doi:10.4314/ahs.v19i2.23 · Cited by 53
Aryati, A., Trimarsanto, H., Yohan, B., Wardhani, P., Fahri, S., & Sasmono, R. T. (2013) · BMC Infectious Diseases · doi:10.1186/1471-2334-13-611 · Cited by 58
“The genome consists of single-stranded positive-sense RNA which encodes three structural (C, prM/M, E) and seven non-structural proteins (NS1, NS2A, NS2B, NS3, NS4A, NS4B, NS5) [1].”
BackgroundInfluentialDengue Infection and Miscarriage: A Prospective Case Control Study
Tan, P. C., Soe, M. Z., Lay, K. S., Wang, S. M., Sekaran, S. D., & Omar, S. Z. (2012) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0001637 · Cited by 52
“Each year there is an estimated 100 million dengue infections [1], 500 thousand hospitalisations due to severe dengue illness [2] and 25 thousand dengue deaths [1] worldwide.”
Silva, E. M., Conde, J. N., Allonso, D., Nogueira, M. L., & Mohana‐Borges, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057514 · Cited by 52
“It is estimated that nearly half of the worldwide population lives in risk areas and that fifty to one hundred million infections occur each year, including 500,000 hospitalizations of patients with severe dengue illness [1,2].”
BackgroundSeidahmed, O. M. E., Hassan, S. A., Soghaier, M. A., Siam, H. A. M., Ahmed, F. T. A., Elkarsany, M. M., & Sulaiman, S. M. (2012) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0001821 · Cited by 52
“The incidence of dengue has increased over ten-fold over the last three decades with an estimated 50 million cases in over 100 countries [1], [2].”
BackgroundFirst Isolation of Dengue Virus from the 2010 Epidemic in Nepal
Pandey, B. D., Nabeshima, T., Pandey, K., Rajendra, S. P., Shah, Y., Adhikari, B. R., Gupta, G., Gautam, I., Tun, M. M. N., Uchida, R., et al. (2013) · Tropical Medicine and Health · doi:10.2149/tmh.2012-17 · Cited by 52
“Dengue hemorrhagic fever (DHF), the severe form of the disease, is endemic and frequently intensifies into epidemics in the countries of Southeast Asia (Laos, Cambodia, Vietnam, Singapore, Indonesia and Thailand), resulting in more cases and deaths [1, 2].”
BackgroundVaccination Against Dengue: Challenges and Current Developments
Guy, B., Lang, J., Saville, M. K., & Jackson, N. (2015) · Annual Review of Medicine · doi:10.1146/annurev-med-091014-090848 · Cited by 52
“In conclusion, the development of a dengue vaccine requires a long-standing and continuous effort from private and public organizations to eventually bring a solution to the still growing and worldwide problem represented by dengue (1, 6).”
BackgroundZhang, Y., Wang, T., Liu, K., Xia, Y., Lu, Y., Jing, Q., Yang, Z., Hu, W., & Lu, J. (2016) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0004473 · Cited by 54
“There are currently no licensed vaccines or specific therapeutics, and the only way of controlling dengue is vector control, though with limited success [5].”
BackgroundA novel multiplex isothermal amplification method for rapid detection and identification of viruses
Nyan, D.-C., & Swinson, K. L. (2015) · Scientific Reports · doi:10.1038/srep17925 · Cited by 52
Three Decades of Dengue Surveillance in Five Highly Endemic South East Asian Countries
Wartel, T. A., Prayitno, A., Hadinegoro, S. R., Capeding, M. R., Thisyakorn, U., Tran, N. H., Moureau, A., Bouckenooghe, A. R., Nealon, J., & Taurel, A.-F. (2016) · Asia Pacific Journal of Public Health · doi:10.1177/1010539516675701 · Cited by 52
Genetic Determinants of the Re-Emergence of Arboviral Diseases
Ketkar, H., Herman, D., & Wang, P. (2019) · Viruses · doi:10.3390/v11020150 · Cited by 52
“Severity of the disease was also found to be greater with a prolonged interval between primary and secondary dengue infection in island outbreaks [17].”
BackgroundTajudeen, Y. A., Oladunjoye, I. O., Mustapha, M. O., Mustapha, S. T., & Ajide-Bamigboye, N. T. (2021) · Health Promotion Perspectives · doi:10.34172/hpp.2021.48 · Cited by 61
Dengue, Chikungunya, and Zika: The Causes and Threats of Emerging and Re-emerging Arboviral Diseases
Soni, S., Gill, V. J. S., Anusheel, Singh, J., Chhabra, J., Gill, G. P. S., & Bakshi, R. (2023) · Cureus · doi:10.7759/cureus.41717 · Cited by 93
“This will result in disseminated intravascular coagulation, followed by vascular collapse, which may lead to the patient's death [21].”
BackgroundWen, T., Lin, M.-H., & Fang, C. (2012) · Annals of the Association of American Geographers · doi:10.1080/00045608.2012.671130 · Cited by 51
“The clinical manifestations of dengue include DF, dengue hemorrhagic fever (DHF), and the most severe and potentially fatal dengue shock syndrome (DSS; Guzman et al. 2010).”
BackgroundHsieh, S., Wu, Y.-C., Zou, G., Nerurkar, V. R., Shi, P., & Wang, W. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.610428 · Cited by 51
“The four serotypes of dengue virus (DENV1, DENV2, DENV3, and DENV4)(2) belonging to the genus Flavivirus in the family Flaviviridae are the leading cause of mosquito-borne diseases in humans in the tropical and subtropical regions (1, 2).”
BackgroundHaralambieva, I. H., Ovsyannikova, I. G., Kennedy, R. B., Larrabee, B. R., Pankratz, V. S., & Poland, G. A. (2013) · Human Immunology · doi:10.1016/j.humimm.2013.06.031 · Cited by 51
Interferon-mediated ISG15 conjugation restricts dengue virus 2 replication
Hishiki, T., Han, Q., Arimoto, K., Shimotohno, K., Igarashi, T., Vasudevan, S. G., Suzuki, Y., & Yamamoto, N. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.04.081 · Cited by 51
Implications of Dengue Outbreaks for Blood Supply, Australia
Faddy, H. M., Seed, C. R., Fryk, J. J., Hyland, C. A., Ritchie, S. A., Taylor, C. T., Merwe, K. L. V. D., Flower, R. L., & McBride, W. J. H. (2013) · Emerging infectious diseases · doi:10.3201/eid1905.121664 · Cited by 51
“Dengue virus types 1–4 (DENV-1–4) are emerging or reemerging in many regions of the world (1,2), including Australia (3).”
Genetic and phenotypic characterization of sylvatic dengue virus type 4 strains
Rossi, S. L., Nasar, F., Cardosa, J., Mayer, S. V., Tesh, R. B., Hanley, K. A., Weaver, S. C., & Vasilakis, N. (2011) · Virology · doi:10.1016/j.virol.2011.11.018 · Cited by 51
A glance at subgenomic flavivirus RNAs and microRNAs in flavivirus infections
Bavia, L., Mosimann, A. L. P., Aoki, M. N., & dos Santos, C. N. D. (2016) · Virology Journal · doi:10.1186/s12985-016-0541-3 · Cited by 61
“Dengue fever can progress to severe conditions, such as dengue haemorrhagic fever (DHF) and dengue shock syndrome (DSS) [90].”
InfluentialClinical and virological characteristics of dengue in Surabaya, Indonesia
Wardhani, P., Aryati, A., Yohan, B., Trimarsanto, H., Setianingsih, T. Y., Puspitasari, D., Arfijanto, M. V., Bramantono, B., Suharto, S., & Sasmono, R. T. (2017) · PLoS ONE · doi:10.1371/journal.pone.0178443 · Cited by 51
Solanki, S., Soni, A., Pandey, M. K., Biradar, A. M., & Sumana, G. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b14391 · Cited by 54
Dengue Virus Infection Activates Interleukin-1β to Induce Tissue Injury and Vascular Leakage
Pan, P., Qi, Z., Liu, W., Wang, W., Yu, Z., Lao, Z., Zhang, W., Shen, M., Wan, P., Xiao, F., et al. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02637 · Cited by 54
“DENV infection causes several diseases, ranging from dengue fever to life-threatening dengue hemorrhagic fever and dengue shock syndrome (Guzman et al., 2010).”
BackgroundDNA-Modified Plasmonic Sensor for the Direct Detection of Virus Biomarkers from the Blood
Vázquez‐Guardado, A., Mehta, F., Jimenez, B., Biswas, A., Ray, K., Baksh, A., Lee, S., Saraf, N., Seal, S., & Chanda, D. (2021) · Nano Letters · doi:10.1021/acs.nanolett.1c01609 · Cited by 51
Mammalian animal models for dengue virus infection: a recent overview
Kayesh, M. E. H., & Tsukiyama–Kohara, K. (2021) · Archives of Virology · doi:10.1007/s00705-021-05298-2 · Cited by 56
“Dengue, caused by dengue virus (DENV), is one of the most important arthropod-borne human viral infections in many tropical and subtropical areas [39, 128].”
BackgroundKalimuddin, S., Chia, P. Y., Low, J. G. H., & Ooi, E. E. (2025) · Clinical Microbiology Reviews · doi:10.1128/cmr.00244-24 · Cited by 84
“Not only is cross-protective immunity short-lived, but adaptive immune response to one DENV appears to increase the risk of severe secondary infection with a heterolo gous DENV (82).”
Bayesian Analysis for Inference of an Emerging Epidemic: Citrus Canker in Urban Landscapes
Neri, F. M., Cook, A. R., Gibson, G. J., Gottwald, T. R., & Gilligan, C. A. (2014) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003587 · Cited by 50
“emerging diseases pose new threats to human health [2–6],”
BackgroundSmith, J. L., Stein, D. A., Shum, D., Fischer, M. A., Radu, C., Bhinder, B., Djaballah, H., Nelson, J. A., Früh, K., & Hirsch, A. J. (2014) · Journal of Virology · doi:10.1128/jvi.00365-14 · Cited by 53
Freire, J. M., Santos, N. C., Veiga, A. S., Poian, A. T. D., & Castanho, M. A. R. B. (2015) · FEBS Journal · doi:10.1111/febs.13274 · Cited by 50
Projected Impact of Dengue Vaccination in Yucatán, Mexico
Hladish, T. J., Pearson, C. A. B., Chao, D. L., Rojas, D. P., Recchia, G. L., Gómez‐Dantés, H., Halloran, M. E., Pulliam, J. R. C., & Longini, I. M. (2016) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0004661 · Cited by 57
“To accurately model the impact of potential vaccination strategies, we must account for the primary mechanisms that influence dengue transmission: mosquito population dynamics and behavior [10, 19, 20], seasonal influences on these factors [21, 22], human movement and demography [23, 24], the build-up of strain-specif…”
BackgroundInfluentialJeffries, C. L., & Walker, T. (2016) · Current Tropical Medicine Reports · doi:10.1007/s40475-016-0066-2 · Cited by 50
A Role for Human Skin Mast Cells in Dengue Virus Infection and Systemic Spread
Troupin, A., Shirley, D. L., Londono-Renteria, B. L., Watson, A. M., McHale, C. C., Hall, A., Hartstone‐Rose, A., Klimstra, W. B., Gomez, G., & Colpitts, T. M. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600846 · Cited by 50
“The development of a safe and effective vaccine has been hindered by the phenomenon of Ab-dependent enhancement, where Abs against one serotype can lead to severe disease, such as dengue hemorrhagic fever and dengue shock syndrome, upon infection with a second serotype (8, 12, 13).”
BackgroundThe association between obesity and dengue virus (DENV) infection in hospitalised patients
Tan, V. P. K., Ngim, C. F., Lee, E. Z., Ramadas, A., Pong, L. Y., Ng, J. I., Hassan, S. S., Ng, X. Y., & Dhanoa, A. (2018) · PLoS ONE · doi:10.1371/journal.pone.0200698 · Cited by 50
“In addition to the various virologic factors, several host and clinical factors thought to confer risk of developing more severe form of dengue have been investigated, including host immune status, genetic susceptibility, gender, age, pregnancy and the presence of comorbidities [2, 5].”
BackgroundNascimento, E. J. M., Hottz, E. D., García-Bates, T. M., Bozza, F. A., Marques, E. T. A., & Barratt‐Boyes, S. M. (2014) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2014010212 · Cited by 52
Differential Requirements in Endocytic Trafficking for Penetration of Dengue Virus
Acosta, E. G., Castilla, V., & Damonte, E. B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044835 · Cited by 49
“As a consequence of the increased re-emergence and rapid spread of flavivirus infections in the last decades, dengue is currently endemic in more than 100 countries and is considered the most prevalent arthropod-borne disease worldwide [1,2].”
BackgroundT cell immunity to dengue virus and implications for vaccine design
Rivino, L. (2015) · Expert Review of Vaccines · doi:10.1586/14760584.2016.1116948 · Cited by 49
“DENV co-circulates as four infectious serotypes (DENV 1 to 4) transmitted by the Aedes mosquitoes.[2] Infection with DENV causes a wide spectrum of clinical manifesta-”
BackgroundHowe, M. K., Speer, B. L., Hughes, P. F., Loiselle, D. R., Vasudevan, S. G., & Haystead, T. (2016) · Antiviral Research · doi:10.1016/j.antiviral.2016.03.017 · Cited by 49
“In 1970, DENV epidemics had only been reported in nine countries, but by 2009, DENV was reported to be endemic in over 100 countries worldwide (1).”
BackgroundAnusuya, S., & Gromiha, M. M. (2016) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2016.1234416 · Cited by 49
“5 billion people live in areas prone to dengue infection (Guzman et al., 2010).”
BackgroundWeng, Z., Shao, X., Graf, D., Wang, C., Klein, C. D. P., Wang, J., & Zhou, G. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.09.063 · Cited by 49
Lim, X.-X., Chandramohan, A., Lim, X. Y., Crowe, J. E., Lok, S., & Anand, G. S. (2017) · Structure · doi:10.1016/j.str.2017.07.007 · Cited by 49
“The antigenic diversity in viruses of the four co-circulating DENV serotypes (DENV1-4) (Guzman et al., 2010) greatly limit the development of dengue vaccines and antiviral therapeutics.”
BackgroundDevelopment of antibody biomarkers of long term and recent dengue virus infections
Nascimento, E. J. M., Huleatt, J. W., Cordeiro, M. T., Castanha, P. M. S., George, J. K., Grebe, E., Welte, A., Brown, M., Burke, D. S., & Marques, E. T. A. (2018) · Journal of Virological Methods · doi:10.1016/j.jviromet.2018.04.009 · Cited by 49
A non-optical multiplexed PCR diagnostic platform for serotype-specific detection of dengue virus
Ze, Y., Ramshani, Z., Waggoner, J. J., Pinsky, B. A., Senapati, S., & Chang, H. (2020) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2020.127854 · Cited by 49
Metadata
- Authors
- Guzman, M. G., Halstead, S. B., Artsob, H., Buchy, P., Farrar, J., Gubler, D. J., Hunsperger, E., Kroeger, A., Margolis, H. S., Martínez, E., Nathan, M. B., Pelegrino, J. L., Simmons, C., Yoksan, S., & Peeling, R. W.
- Affiliations
- Public Health Agency of Canada (CA)
- Institut Pasteur du Cambodge (KH)
- Oxford University Clinical Research Unit (VN)
- National University of Singapore (SG)
- Centers for Disease Control and Prevention (US)
- World Bank (US)
- Instituto de Medicina Tropical “Pedro Kourí” (CU)
- World Health Organization (CH)
- Mahidol University (TH)
- Corresponding author
- Peeling, Rosanna W.
- ORCID
- Venue
- Nature Reviews Microbiology
- Published
- 2010-12
- Volume
- 8
- Issue
- S12
- Pages
- S7-S16
- ISSN
- 1740-1526 (ISSN-L)
- 1740-1534
- PMC
- PMC4333201
- OpenAlex
- W2042479028
- Cited by
- 2,082
- References
- 130
- Citations by year
- 2026: 68 · 2025: 104 · 2024: 94 · 2023: 135 · 2022: 116 · 2021: 133 · 2020: 140 · 2019: 127 · 2018: 142 · 2017: 151 · 2016: 163 · 2015: 189 · 2014: 186 · 2013: 161 · 2012: 132
- FWCI
- 15.35
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Reviews Microbiology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- Minerva Access (University of Melbourne) (submittedVersion)
- Funders
- Wellcome Trust (084368)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Mosquito-borne diseases and control
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Dengue and Mosquito Control Research
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Vectors
- Keywords
- dengue, dengue hemorrhagic fever, arboviruses, dengue serotypes, vector-borne diseases, dengue surveillance, outbreak response, integrated vector management, early diagnosis, dengue vaccine, antiviral agents, dengue control
- MeSH terms
- Americas, Asia, Southeastern, Dengue, Dengue Virus, Hospitalization, Humans, Insect Control, Pacific Islands
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.